- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
This is a Virtual Event for PsychU members in Maryland, Washington, DC, and Virginia.
Trace amines and trace amine-associated receptors (TAAR) are found throughout the brain and peripheral tissues and have modulating effects on neurotransmitters including dopamine, glutamate, and serotonin.1,2 The speaker(s) will discuss what are some of the potential effects of TAAR1 on neurotransmitter signaling related to schizophrenia and some of the preclinical data, as well as share the potential role of TAAR1 beyond schizophrenia.
Objectives:
- Summarize the Unmet Needs of Schizophrenia as it Relates to Neural Circuitry
- Introduction to Trace Amines (TA) and Trace Amine-Associated Receptors (TAARs) and Their Potential Relationship to Schizophrenia
- Discuss Potential Modulating Effects of TAAR1 on Neurotransmitter Signaling Associated with Schizophrenia Pathophysiology
Featuring
Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS
Speaker Dennis Sholler, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Born This Way? The Role Of Early Life Stress In Adult Mental Illness
April 16 12:00 pm to 1:00 pm -
Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
April 24 12:00 pm to 1:00 pm -
Virtual Event – Born This Way? The Role Of Early Life Stress In Adult Mental Illness
April 30 6:30 pm to 7:30 pm
Registration
Related Resources
-
Post Traumatic Stress Disorder: Disease Burden
Infographic March 25, 2025This infographic examines the disease burden of PTSD, highlighting the impact on quality of life and functioning as well as the economic burden of PTSD.
-
Treatment in PTSD: Guidelines, Current Treatment Landscape, & Unmet Needs (Infographic)
Infographic March 25, 2025This infographic examines the current evidence-based guidelines for the treatment of PTSD in the United States, including discussion of psychotherapy, pharmacotherapy, and barriers to treatment.
-
World Bipolar Day – Bipolar Together
Video March 6, 2025Join us as both providers and patients share their thoughts and perspectives of on the significance of World Bipolar Day and the impact of living with bipolar disorder.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: